Ehealth AI Stock Analysis
Want to see EHTH full AI Analyst Report?
Ehealth (EHTH) AI Stock Analysis
Ehealth
(NASDAQ:EHTH)
The score is held back primarily by weak technicals (price far below key moving averages with bearish momentum) and financial-quality concerns driven by historically inconsistent cash generation and a notable recent equity decline. These risks are partly offset by improved profitability versus prior years and management’s reaffirmed guidance focused on cost reductions and operating cash flow improvement, but valuation remains difficult to support with a negative P/E and no dividend yield provided.
Ehealth (EHTH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $11.32M
- Dividend Yield
- ―
- Average Volume (3M)
- 428.08K
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 1.20
- Revenue Growth
- -13.60%
- EPS Growth
- -899.66%
- Country
- US
- Employees
- 1,665
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Brokers
Ehealth Business Overview & Revenue Model
Company Description
eHealth, Inc. operates a digital health insurance marketplace within the United States, dedicated to engaging consumers, educating them, and simplifying the health insurance enrollment process. Its operations are categorized into two main divisions:...
How the Company Makes Money
eHealth primarily makes money by acting as a distribution and enrollment channel for health insurers and related plan providers. Its core revenue is generated when a consumer enrolls in an insurance plan through eHealth’s websites, call centers, or a...
Ehealth Earnings Call Summary
The call presented a mixed picture. Management highlighted substantial cost reductions, sharply improved year-to-date cash flow, favorable early AEP demand, early retention and ancillary cross-sell gains from the Lifetime Advisory Model, new carrier and distribution partnerships, and reaffirmed guidance. However, current-quarter financial performance remained weak, with significant declines in revenue, applications, Medicare tail revenue, Medicare gross profit, segment economics and cash balances, alongside ongoing preferred equity capital structure discussions. The positive operational and strategic developments were offset by the magnitude of the current financial declines, resulting in a balanced outlook.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management reaffirmed its fiscal year 2026 guidance ranges, including full-year operating cash flow at “breakeven or better,” 2026 net adjustment revenue in the range of $17 million to $20 million, total 2026 cost savings of more than $60 million, fixed cost savings of approximately $30 million, and a reduction in 2026 variable and fixed operating costs and expenses by approximately $90 million compared with 2025; fourth quarter operating cash flow is currently expected to also show a meaningful improvement compared to Q4 of '25, while the company’s longer-term objectives include returning to mid-single-digit revenue growth in 2027, accompanied by expanded adjusted EBITDA margins and positive operating cash flow.
Ehealth Financial Statement Overview
Summary
Income statement shows a meaningful turnaround to profitability versus 2021–2023 losses, and leverage appears moderate-to-low. However, cash flow consistency is a major weakness (multi-year negative OCF/FCF through 2025 with volatility), and the sharp equity decline from 2025 to TTM 2026 reduces the capital cushion.
Income Statement
68PositiveBalance Sheet
72PositiveCash Flow
43Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 469.10M | 554.01M | 532.41M | 452.87M | 405.36M | 538.20M |
| Gross Profit | 462.63M | 540.25M | 530.62M | 451.10M | 403.71M | 536.21M |
| EBITDA | 64.28M | 83.25M | 46.81M | 295.00K | -77.65M | -105.18M |
| Net Income | 22.95M | 40.04M | 10.06M | -28.21M | -88.72M | -104.38M |
Balance Sheet | ||||||
| Total Assets | 1.11B | 1.26B | 1.16B | 1.11B | 1.11B | 1.15B |
| Cash, Cash Equivalents and Short-Term Investments | 88.12M | 77.22M | 82.24M | 121.65M | 144.40M | 123.23M |
| Total Debt | 131.59M | 134.35M | 96.92M | 103.16M | 106.80M | 41.37M |
| Total Liabilities | 200.92M | 288.82M | 567.00M | 209.26M | 461.66M | 399.77M |
| Stockholders Equity | 912.72M | 973.65M | 588.43M | 904.08M | 650.96M | 749.52M |
Cash Flow | ||||||
| Free Cash Flow | 12.34M | -40.65M | -31.22M | -17.47M | -42.38M | -183.48M |
| Operating Cash Flow | 19.38M | -25.34M | -18.37M | -6.69M | -26.87M | -162.62M |
| Investing Cash Flow | -61.61M | 25.43M | -48.42M | -15.89M | 25.86M | -12.63M |
| Financing Cash Flow | 36.71M | 34.29M | -9.32M | -6.22M | 63.84M | 213.24M |
Ehealth Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EHTH, the sentiment is Negative. The current price of 0.35 is below the 20-day moving average (MA) of 0.50, below the 50-day MA of 0.65, and below the 200-day MA of 1.33, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 26.59 is Positive, neither overbought nor oversold. The STOCH value of 5.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EHTH.
Ehealth Risk Analysis
Ehealth disclosed 41 risk factors in its most recent earnings report. Ehealth reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksEhealth Peers Comparison
Overall Rating
WDH83Outperform
HUIZ68Neutral
SLQT63Neutral
EHTH51Neutral
XGPU41Neutral
AIFU34Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | $364.49M | 0.60 | 10.56% | 5.94% | 76.04% | 25.89% | |
| 68Neutral | $22.94M | 0.28 | 6.41% | ― | ― | ― | |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 63Neutral | $58.41M | -33.40 | 11.28% | ― | 0.42% | -111.55% | |
| 51Neutral | $11.32M | -0.36 | 2.70% | ― | -13.60% | -899.66% | |
| 41Neutral | $3.32M | -0.11 | -88.14% | ― | -20.76% | 89.78% | |
| 34Underperform | $706.17M | -0.14 | -150.44% | ― | -47.11% | -87.98% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| EHTH | Ehealth | 0.35 | -3.25 | -90.31% | |
| AIFU | Fanhua Inc. | 9.76 | -66.04 | -87.13% | |
| XGPU | Reliance Global Group | 1.88 | -26.94 | -93.48% | |
| HUIZ | Huize Holding Ltd. | 2.27 | -0.83 | -26.77% | |
| SLQT | SelectQuote Inc | 6.51 | -21.29 | -76.58% | |
| WDH | Waterdrop, Inc. ADR Class A | 1.01 | -0.56 | -35.63% |
Ehealth Corporate Events
eHealth Faces Nasdaq Noncompliance, Weighs Reverse Stock Split
NegativeOn October 14, 2026, eHealth, Inc. disclosed that it received a notice from Nasdaq stating its common stock had closed below the $1.00 minimum bid price for 30 consecutive business days, putting the company out of compliance with the Nasdaq Global Se...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
